Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Danaher Corporation

NYSE

Market Cap.

194.64B

Avg. Volume

2.62M

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze Danaher Corporation!

Still processing it, give me a bit more time...

Danaher Corporation News

Danaher Corporation Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

Website screenshot
HealthcareMedical - Diagnostics & Research
danaher.com

About Danaher Corporation

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.

Danaher Corporation Earnings & Revenue

Danaher Corporation Financials

Table Compare

Compare DHR metrics with:

   

Earnings & Growth

DHR

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

DHR

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

DHR

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

DHR

None

Debt Ratio

--

--

Quick Ratio

--

--

 

Danaher Corporation Income

Danaher Corporation Balance Sheet

Danaher Corporation Cash Flow

Danaher Corporation Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityBuy
Return on AssetsBuy
Debt/Equity RatioBuy
Price/Earnings RatioStrong Buy
Price/Book RatioBuy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Danaher Corporation Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

1.0500

Payment DateDividendFrequency
2024-07-260.27Quarterly
2024-04-260.27Quarterly
2024-01-260.24Quarterly
2023-10-270.27Quarterly
2023-07-280.27Quarterly

Historical Market Cap

Shares Outstanding

Danaher Corporation Executives

NameRole
Mr. Rainer M. BlairPresident, Chief Executive Officer & Director
Mr. Joakim WeidemanisExecutive Vice President
Mr. Matthew R. McGrewChief Financial Officer & Executive Vice President
Dr. Jose-Carlos Gutierrez-Ramos Ph.D.Senior Vice President & Chief Science Officer
Mr. Brian W. EllisSenior Vice President, General Counsel & Chief Compliance Officer
NameRoleGenderDate of BirthPay
Mr. Rainer M. BlairPresident, Chief Executive Officer & DirectorMale19645.33M
Mr. Joakim WeidemanisExecutive Vice PresidentMale19692.76M
Mr. Matthew R. McGrewChief Financial Officer & Executive Vice PresidentMale19722.56M
Dr. Jose-Carlos Gutierrez-Ramos Ph.D.Senior Vice President & Chief Science Officer19622.09M
Mr. Brian W. EllisSenior Vice President, General Counsel & Chief Compliance OfficerMale19671.93M

Danaher Corporation Insider Trades

Date15 May
NameSCHWIETERS JOHN T
RoleDirector
TransactionAcquired
TypeA-Award
Shares390
Date15 May
NameSCHWIETERS JOHN T
RoleDirector
TransactionAcquired
TypeA-Award
Shares1081
Date15 May
NameMega Jessica L
RoleDirector
TransactionAcquired
TypeA-Award
Shares390
Date15 May
NameMega Jessica L
RoleDirector
TransactionAcquired
TypeA-Award
Shares1081
Date15 May
NameRiley Christopher Paul
RoleExecutive Vice President
TransactionDisposed
TypeF-InKind
Shares320
DateNameRoleTransactionTypeShares
15 MaySCHWIETERS JOHN TDirectorAcquiredA-Award390
15 MaySCHWIETERS JOHN TDirectorAcquiredA-Award1081
15 MayMega Jessica LDirectorAcquiredA-Award390
15 MayMega Jessica LDirectorAcquiredA-Award1081
15 MayRiley Christopher PaulExecutive Vice PresidentDisposedF-InKind320

Discover More

Streamlined Academy

Danaher Corporation

NYSE

Market Cap.

194.64B

Avg. Volume

2.62M

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Danaher Corporation News

Danaher Corporation Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

Danaher Corporation Earnings & Revenue

Danaher Corporation Income

Danaher Corporation Balance Sheet

Danaher Corporation Cash Flow

Danaher Corporation Financials Over Time

Danaher Corporation Executives

NameRole
Mr. Rainer M. BlairPresident, Chief Executive Officer & Director
Mr. Joakim WeidemanisExecutive Vice President
Mr. Matthew R. McGrewChief Financial Officer & Executive Vice President
Dr. Jose-Carlos Gutierrez-Ramos Ph.D.Senior Vice President & Chief Science Officer
Mr. Brian W. EllisSenior Vice President, General Counsel & Chief Compliance Officer
NameRoleGenderDate of BirthPay
Mr. Rainer M. BlairPresident, Chief Executive Officer & DirectorMale19645.33M
Mr. Joakim WeidemanisExecutive Vice PresidentMale19692.76M
Mr. Matthew R. McGrewChief Financial Officer & Executive Vice PresidentMale19722.56M
Dr. Jose-Carlos Gutierrez-Ramos Ph.D.Senior Vice President & Chief Science Officer19622.09M
Mr. Brian W. EllisSenior Vice President, General Counsel & Chief Compliance OfficerMale19671.93M

Danaher Corporation Insider Trades

Date15 May
NameSCHWIETERS JOHN T
RoleDirector
TransactionAcquired
TypeA-Award
Shares390
Date15 May
NameSCHWIETERS JOHN T
RoleDirector
TransactionAcquired
TypeA-Award
Shares1081
Date15 May
NameMega Jessica L
RoleDirector
TransactionAcquired
TypeA-Award
Shares390
Date15 May
NameMega Jessica L
RoleDirector
TransactionAcquired
TypeA-Award
Shares1081
Date15 May
NameRiley Christopher Paul
RoleExecutive Vice President
TransactionDisposed
TypeF-InKind
Shares320
DateNameRoleTransactionTypeShares
15 MaySCHWIETERS JOHN TDirectorAcquiredA-Award390
15 MaySCHWIETERS JOHN TDirectorAcquiredA-Award1081
15 MayMega Jessica LDirectorAcquiredA-Award390
15 MayMega Jessica LDirectorAcquiredA-Award1081
15 MayRiley Christopher PaulExecutive Vice PresidentDisposedF-InKind320

Streamlined Academy

Website screenshot
HealthcareMedical - Diagnostics & Research
danaher.com

About Danaher Corporation

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze Danaher Corporation!

Still processing it, give me a bit more time...

Danaher Corporation Financials

Table Compare

Compare DHR metrics with:

   

Earnings & Growth

DHR

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

DHR

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

DHR

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

DHR

None

Debt Ratio

--

--

Quick Ratio

--

--

 

Danaher Corporation Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

1.0500

Payment DateDividendFrequency
2024-07-260.27Quarterly
2024-04-260.27Quarterly
2024-01-260.24Quarterly
2023-10-270.27Quarterly
2023-07-280.27Quarterly

Danaher Corporation Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityBuy
Return on AssetsBuy
Debt/Equity RatioBuy
Price/Earnings RatioStrong Buy
Price/Book RatioBuy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More